Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Decio Eizirik; Alexander Balhuizen; Nick Devoogdt; Sam Massa; Luc Bouwens; Iris Mathijs

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Decio Eizirik (Inventor), Alexander Balhuizen (Inventor), Nick Devoogdt (Inventor), Sam Massa (Inventor), Luc Bouwens (Inventor), Iris Mathijs (Inventor)

Research output: Patent

Abstract

The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

Original language	English
Patent number	US11243214
Publication status	Published - 2022

Cite this

@misc{fab82eb7f54d4d5795ba2762d2f9f7f1,

title = "Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells",

abstract = "The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).",

author = "Decio Eizirik and Alexander Balhuizen and Nick Devoogdt and Sam Massa and Luc Bouwens and Iris Mathijs",

year = "2022",

language = "English",

type = "Patent",

note = "US11243214",

}

TY - PAT

T1 - Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

AU - Eizirik, Decio

AU - Balhuizen, Alexander

AU - Devoogdt, Nick

AU - Massa, Sam

AU - Bouwens, Luc

AU - Mathijs, Iris

PY - 2022

Y1 - 2022

N2 - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

AB - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

UR - http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US11243214&F=0

M3 - Patent

M1 - US11243214

ER -

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Abstract

Other files and links

Fingerprint

IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Cite this

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Abstract

Other files and links

Fingerprint

Projects

IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Cite this